Bobossi-Serengbe G, Gody J-C, Fioboy R, Elowa J-B, Manirakiza A
Université de Bangui, Avenue des Martyrs, BP 1450, Bangui, République centrafricaine.
Bull Soc Pathol Exot. 2015 Mar;108(2):107-11. doi: 10.1007/s13149-015-0428-3. Epub 2015 Mar 2.
The management of severe malaria is a major challenge in the health care services in sub-Saharan Africa. This study aimed to assess the efficacy and safety of artemether and quinine in severe malaria at Complexe pédiatrique of Bangui, Central African Republic. A total of 212 children among 1125 hospital admissions (18.8%), and aged 6 to 59 months were randomly treated with artemether and quinine. Anemia (58.5%) and seizures (33.5%) were the major syndromes observed. On the third day of follow up, a regression of clinical signs and parasite clearance were observed in 98.1% of children treated with artemether and 97.1% of children treated with quinine. The death rate was 2.3% due to anemic and neurological forms. These findings show that the artemether and quinine have similar efficacy. Hence, associated with adequate intensive health care, the use of these antimalarial drugs can significantly reduce mortality from severe malaria in the Central African Republic.
在撒哈拉以南非洲的医疗服务中,重症疟疾的管理是一项重大挑战。本研究旨在评估在中非共和国班吉儿科综合医院使用蒿甲醚和奎宁治疗重症疟疾的疗效和安全性。在1125例住院患者中,共有212名年龄在6至59个月的儿童(占18.8%)被随机给予蒿甲醚和奎宁治疗。观察到的主要症状为贫血(58.5%)和惊厥(33.5%)。在随访的第三天,接受蒿甲醚治疗的儿童中有98.1%以及接受奎宁治疗的儿童中有97.1%的临床症状出现消退且疟原虫清除。因贫血和神经症状导致的死亡率为2.3%。这些研究结果表明,蒿甲醚和奎宁具有相似的疗效。因此,与充分的强化医疗保健相结合,使用这些抗疟药物可显著降低中非共和国重症疟疾的死亡率。